Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 1 of 1 (100%) have an AI response strategy ready
Gorgio International Holding LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner within 1 distinct art unit. The concentration of the portfolio into a single point of contact indicates a narrow prosecution focus for the current pending matters. This structure allows for a highly targeted strategy that addresses the specific requirements of 1 technical group.
BOECKELMAN, JACOB A is the busiest examiner for the company with 1 pending office action. This examiner accounts for the entirety of the pending workload. Practitioners should note that the prosecution strategy for this portfolio is currently tied to the specific tendencies of this 1 examiner and 1 art unit. Since there is only 1 pending action, the company does not currently face the challenge of coordinating across multiple examiner preferences or art unit policies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.6% | +46.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18860664 | Malt Supplement Containing Oleocanthal, with Anti-inflammatory, Antioxidant, and Anti-cancer Properties | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860664 | Malt Supplement Containing Oleocanthal, with Anti-inflammatory, Antioxidant, and Anti-cancer Properties | BOECKELMAN, JACOB A | 1655 | §112 | Non-Final OA | — | AI Ready | Oct 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGorgio International Holding LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jacob A Boeckelman has the most, with 1 of Gorgio International Holding LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.